Search clinical trials for: Ticagrelor

Total 446 results

Yonsei University

Recruiting

Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Acute Coronary Syndrome

Korea, Republic of
Maasstad Hospital
Medtronic

Completed

Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI (DAPT-STEMI)

Myocardial Infarction | Cardiovascular Disease

Norway, Netherlands, Poland, Switzerland
Mazandaran University of Medical Sciences

Completed

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke (TACAMINIS)

Ischemic Stroke | Transient Ischemic Attack

Iran, Islamic Republic of
AstraZeneca

Completed

An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease

Stable Coronary Artery Disease

Philippines, Japan
Boehringer Ingelheim

Completed

Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor

Healthy

Germany
Icahn School of Medicine at Mount Sinai
AstraZeneca

Completed

Reversing Ticagrelor's Effects With Fresh Platelets

Coronary Artery Disease

United States
Zuyderland Medisch Centrum
Boehringer Ingelheim

Recruiting

Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI (RE-DUAL PCI)

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Atrial Fibrillation

Netherlands
AstraZeneca

Completed

Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor

Healthy

United States
Hospital Israelita Albert Einstein

Recruiting

Platelet Sub-study of the Neomindset Trial

Acute Coronary Syndrome

Brazil
University of Florida
AstraZeneca

Active, not recruiting

Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus (OPTIMUS-7)

Coronary Artery Disease | Diabetes Mellitus, Type 2

United States
AstraZeneca

Completed

PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4) (HESTIA4)

Sickle Cell Disease

Belgium, United Kingdom, Italy, Spain, Kenya, Lebanon
Aggredyne, Inc.

Completed

Study of AggreGuide A-100 (ADP) Assay

Risk Factor, Cardiovascular | Platelet Dysfunction Due to Drugs
Chang Gung Memorial Hospital

Unknown

Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit

Peripheral Artery Disease
University of Florida
Scott R. MacKenzie Foundation

Recruiting

Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

Coronary Artery Disease

United States
Yonsei University

Not yet recruiting

24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial

High Ischemic Risk

Korea, Republic of
RenJi Hospital

Not yet recruiting

Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT) (Tip-HAT)

Liver Transplant; Complications | Pediatric Disease | Hepatic Artery Thrombosis

China
Vastra Gotaland Region
Uppsala University; Gothia Forum - Center for Clinical Trial

Recruiting

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome (TACSI)

Acute Coronary Syndrome

Denmark, Sweden, Norway, Finland, Iceland
Dong-A University

Completed

Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

Acute Coronary Syndrome

Korea, Republic of
HonorHealth Research Institute
Boston Scientific Corporation

Active, not recruiting

SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy (SYNIVUS-DAPT)

Coronary Artery Disease | Atherosclerosis | Stent Placement

United States
The Guthrie Clinic

Recruiting

Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention (FACTPCI)

Percutaneous Coronary Intervention

United States
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Zunyi Medical College

Recruiting

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

STEMI - ST Elevation Myocardial Infarction

China
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Xuanwu Hospital, Beijing

Recruiting

Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis (VISTA)

Ischemic Stroke | Vertebral Artery Stenosis

China
Xijing Hospital

Active, not recruiting

1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon (CAGEFREEII)

Acute Coronary Syndrome | Angioplasty, Balloon | Antiplatelet Drug

China
Seoul National University Hospital
B. Braun Korea Co., Ltd.

Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial (HOST-IDEA)

Stable Angina | Unstable Angina | Non-ST Segment Elevation Myocardial Infarction

Korea, Republic of
Kafrelsheikh University
Ain Shams University

Completed

Ticagrelol Versus Aspirin in Ischemic Stroke

Ischemic Stroke | Acute Stroke

Egypt
Icahn School of Medicine at Mount Sinai
AstraZeneca

Completed

Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention (TWILIGHT)

Cardiovascular Disease | Interventional Cardiology

United States
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Completed

Reversal of the Anti-platelet Effects of Ticagrelor (REVERSAL)

Coronary Artery Disease

China
Hamilton Health Sciences Corporation

Unknown

Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets (REVSTARTS)

Aspirin | Platelet Dysfunction Due to Drugs | Ticagrelor | Transfusion

Canada
The Cleveland Clinic
AstraZeneca

Terminated

Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery (INTREPID)

Myocardial Injury

United States
Shenzhen Second People's Hospital

Not yet recruiting

the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA

Cerebral Amyloid Angiopathy
Icahn School of Medicine at Mount Sinai

Completed

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

Type 2 Diabetes | Peripheral Artery Disease

United States
Newcastle-upon-Tyne Hospitals NHS Trust
AstraZeneca; Newcastle University

Completed

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] (SOCRATES)

Acute Ischaemic Stroke | Transient Ischaemic Attack

Sweden, United States, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, Vietnam, Germany, Philippines, China, Hungary, Romania, Ukraine, Hong Kong, Argentina, Bel... and more
Yong Huo

Completed

Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy

Coronary Heart Disease

China
Yong Chen

Unknown

Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma

China
Shenyang Northern Hospital

Completed

The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease

Coronary Artery Disease | Ticagrelor

China
Fundacion para la Formacion e Investigacion Sanitarias...

Unknown

Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients (Ticagrelor)

Coronary Artery Disease

Spain
The Catholic University of Korea
Chonnam National University Hospital

Completed

TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Acute Myocardial Infarction

Korea, Republic of
Clinical Centre of Serbia

Terminated

On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction (PLATFORM)

Acute ST-elevation Myocardial Infarction

Serbia
Asan Medical Center

Recruiting

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent (OPTIMIZE-APT)

Coronary Artery Disease

Korea, Republic of
Beijing Tiantan Hospital
Ministry of Science and Technology of the People´s Republic of China

Completed

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II (CHANCE-2)

Stroke | Transient Ischemic Attack

China
Ottawa Heart Institute Research Corporation

Terminated

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Percutaneous Coronary Intervention | Ticagrelor | Antiplatelet Therapy | Stable Coronary Syndrome

Canada
Second Affiliated Hospital, School of Medicine,...

Unknown

DUAL Antithrombotic Therapy in Patients With AF and ACS

Atrial Fibrillation | Acute Coronary Syndromes
Deutsches Herzzentrum Muenchen
AstraZeneca

Terminated

Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG (TiCAB)

Coronary Artery Disease | Acute Coronary Syndrome | Stable Angina

Germany, Austria, Switzerland
Medical University of Vienna

Unknown

High "on Treatment" Platelet Reactivity in the Intensive Care Unit

Critical Illness

Austria
The Fourth Affiliated Hospital of China Medical...

Recruiting

A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge

Brain Disease | Vertebral Artery Stenosis

China
Yu Bo
Massachusetts General Hospital

Completed

Paradigm Shift in the Treatment of Patients With ACS

Acute Coronary Syndrome

China
Medstar Health Research Institute

Completed

The ACS Ethnicity Platelet Function Study

Acute Coronary Syndrome

United States

Search clinical trials for: Ticagrelor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations